Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ROCK2 | O75116 | 1/20 | 0.50 |
| ▸ | PIM1 | P11309 | 1/20 | 0.50 |
| ▸ | PIM3 | Q86V86 | 1/20 | 0.50 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.50 |
| ▸ | MGLL | Q99685 | 1/20 | 0.48 |
| ▸ | ENPP3 | O14638 | 1/20 | 0.44 |
| ▸ | CDC7 | O00311 | 2/20 | 0.43 |
| ▸ | ALB | P02768 | 1/20 | 0.43 |
| ▸ | POLB | P06746 | 4/20 | 0.42 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.42 |
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.42 |
| ▸ | APEX1 | P27695 | 3/20 | 0.42 |
| ▸ | RECQL | P46063 | 3/20 | 0.42 |
| ▸ | MEN1 | O00255 | 3/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.42 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | NR4A1 | P22736 | 2/20 | 0.42 |
| ▸ | PTPN7 | P35236 | 2/20 | 0.42 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6840228 | 0.90 | ROCK2 (0.53) | ROCK2PIM1PIM3FFAR4MGLL | |
| SCHEMBL13431113 | 0.86 | ROCK2 (0.47) | ROCK2PIM1PIM3FFAR4MGLL | |
| SCHEMBL693720 | 0.83 | MGLL (0.58) | ROCK2PIM1PIM3FFAR4MGLL | |
| SCHEMBL1356786 | 0.83 | FFAR4 (0.47) | ROCK2PIM1PIM3FFAR4MGLL | |
| SCHEMBL4282844 | 0.82 | ENPP3 (0.56) | FFAR4MGLLENPP3CDC7ALB | |
| SCHEMBL1356949 | 0.81 | PLA2G10 (0.54) | ROCK2PIM1PIM3POLBTDP1 | |
| SCHEMBL6840254 | 0.80 | ROCK2 (0.76) | ROCK2PIM1PIM3POLBTDP1 | |
| SCHEMBL27403900 | 0.79 | CDC7 (0.50) | ROCK2PIM1PIM3FFAR4MGLL | |
| SCHEMBL13243745 | 0.78 | ROCK2 (0.51) | ROCK2PIM1PIM3POLBTDP1 | |
| SCHEMBL6292916 | 0.78 | FFAR4 (0.43) | FFAR4MGLLENPP3CDC7ALB |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110282066-A1 | SCREENING METHOD FOR SUBSTANCE USEFUL AS AGENT FOR TREATING PROSTATE CANCER | ASTELLAS PHARMA INC. (JP) | 2011-11-17 | — | — | US | disclosed |
| US-20110282066-A1 | SCREENING METHOD FOR SUBSTANCE USEFUL AS AGENT FOR TREATING PROSTATE CANCER | ASTELLAS PHARMA INC. (JP) | 2011-11-17 | — | — | US | disclosed |
| US-20110282066-A1 | SCREENING METHOD FOR SUBSTANCE USEFUL AS AGENT FOR TREATING PROSTATE CANCER | ASTELLAS PHARMA INC. (JP) | 2011-11-17 | — | — | US | disclosed |
| EP-2383573-A1 | SCREENING METHOD FOR SUBSTANCE USEFUL AS AGENT FOR TREATING PROSTATE CANCER | Astellas Pharma Inc. (JP) | 2011-11-02 | — | — | EP | disclosed |
| CN-101835747-A | Benzimidazole derivative | ASTELLAS PHARMA INC | 2010-09-15 | — | — | CN | disclosed |
| WO-2010087319-A1 | METHOD FOR SCREENING SUBSTANCE USEFUL AS THERAPEUTIC AGENT FOR PROSTATE CANCER | アステラス製薬株式会社 (JP) | 2010-08-05 | — | — | WO | disclosed |
| US-20100190826-A1 | BENZIMIDAZOLE DERIVATIVE | ASTELLAS PHARMA INC. (JP) | 2010-07-29 | — | — | US | disclosed |
| US-20100190826-A1 | BENZIMIDAZOLE DERIVATIVE | ASTELLAS PHARMA INC. (JP) | 2010-07-29 | — | — | US | disclosed |
| EP-2172454-A1 | BENZIMIDAZOLE DERIVATIVE | Astellas Pharma Inc. (JP) | 2010-04-07 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110282066-A1 | SCREENING METHOD FOR SUBSTANCE USEFUL AS AGENT FOR TREATING PROSTATE CANCER | CYP17A1, KLK3, NR5A1 | ROCK2 2929/4885PIM1 4639/4885PIM3 4673/4885 |
| US-20100190826-A1 | BENZIMIDAZOLE DERIVATIVE | SHBG, SRD5A1, AR | ROCK2 2866/4885PIM1 1770/4885PIM3 1665/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.